American Heart Journal
Volume 151, Issue 4 , Pages 915.e1-915.e7 , April 2006

Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: Results from the FIRE trial

  • Amir Halkin, MD

      Affiliations

    • Cardiovascular Research Foundation, New York, NY
    • ,
  • A. Zaki Masud, MD

      Affiliations

    • Cardiac Interventional Unit, Buffalo General Hospital, Buffalo, NY
    • ,
  • Campbell Rogers, MD

      Affiliations

    • Cardiac Catheterization Laboratory, Brigham and Women's Hospital, Boston, MA
    • ,
  • James Hermiller, MD

      Affiliations

    • Cardiac Catheterization Laboratories, St. Vincent's Hospital, Indianapolis, IN
    • ,
  • Robert Feldman, MD

      Affiliations

    • Ocala Heart Institute, Munroe Regional Medical Center, Ocala, FL
    • ,
  • Patrick Hall, MD

      Affiliations

    • Providence Heart Institute, Providence Hospital, Columbia, SC
    • ,
  • Robert H. Haber, MD

      Affiliations

    • Sanger Clinic, Carolinas HealthCare, Charlotte, NC
    • ,
  • Patrick A. Cambier, MD

      Affiliations

    • Division of Cardiology, Morton Plant Hospital, Clearwater, CA
    • ,
  • Ron P. Caputo, MD

      Affiliations

    • Cardiovascular Laboratory, St. Joseph's Hospital, Syracuse, NY
    • ,
  • Mark Turco, MD

      Affiliations

    • Cardiovascular Institute, Washington Adventist Hospital, Takoma Park, MD
    • ,
  • Richard Kovach, MD

      Affiliations

    • New Jersey heart Institute, Our Lady of Lourdes Medical Center, Camden, NJ
    • ,
  • Bruce Brodie, MD

      Affiliations

    • Moses Cone Heart and Vascular Center, Moses Cone Memorial Hospital, Greensboro, NC
    • ,
  • Howard C. Herrmann, MD

      Affiliations

    • Interventional Cardiology and Cardiac Catheterization Laboratories, University of Pennsylvania Medical Center, Philadelphia, PA
    • ,
  • Richard E. Kuntz, MD

      Affiliations

    • Cardiac Catheterization Laboratory, Brigham and Women's Hospital, Boston, MA
    • ,
  • Jeffrey J. Popma, MD

      Affiliations

    • Cardiac Catheterization Laboratory, Brigham and Women's Hospital, Boston, MA
    • ,
  • Steve Ramee, MD

      Affiliations

    • Ochsner Heart and Vascular Institute, Ochsner Clinic, New Orleans, LA
    • ,
  • David A. Cox, MD

      Affiliations

    • Cardiac Catheterization Laboratory, Mid Carolina Cardiology, Charlotte, NC
    • ,
  • Roxana Mehran, MD

      Affiliations

    • Cardiovascular Research Foundation, New York, NY
    • Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY
    • ,
  • Gregg W. Stone, MD

      Affiliations

    • Cardiovascular Research Foundation, New York, NY
    • Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY
    • Corresponding Author InformationReprint requests: Gregg W. Stone, MD, The Cardiovascular Research Foundation, Columbia University Medical Center, 55 E 59th St, 6th Floor, New York, NY 10022.

Received 27 May 2005 ,Accepted 15 September 2005.

References 

  1. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285–1290
  2. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548–553
  3. Savage MP, Douglas JS, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med. 1997;337:740–747
  4. Hong MK, Mehran R, Dangas G, et al. Are we makinh progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 results. J Am Coll Cardiol. 2001;38:150–154
  5. Keeley EC, Velez CA, O'Neill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38:659–665
  6. Nishida T, Colombo A, Briguori C, et al. Contemporary percutaneous treatment of saphenous vein graft stenosis: immediate and late outcomes. J Invasive Cardiol. 2000;12:505–512
  7. Hanekamp CE, Koolen JJ, Den Heijer P, et al. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: the Venestent study. Catheter Cardiovasc Interv. 2003;60:452–457
  8. Hong MK, Mehran R, Dangas G, et al. Creatine kinase–MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999;100:2400–2405
  9. Wolfram R, Leborgne L, Cheneau E, et al. Comparison of creatine kinase elevation and outcome of comparison of percutaneous coronary intervention for saphenous vein graft in-stent restenosis versus de novo stenosis. Am J Cardiol. 2003;92:980–983
  10. Stephan WJ, O'Keefe JH, Piehler JM, et al. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol. 1996;28:1140–1146
  11. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40:1951–1954
  12. Stone GW, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation. 2001;104:642–647
  13. Ellis SG, Chew D, Chan A, et al. Death following creatine kinase–MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase–MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation. 2002;106:1205–1210
  14. Mehran R, Dangas G, Mintz GS, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation. 2000;101:604–610
  15. Nallamothu BK, Bates ER. Periprocedural myocardial infarction and mortality: causality versus association. J Am Coll Cardiol. 2003;42:1412–1414

PII: S0002-8703(05)00874-4

doi: 10.1016/j.ahj.2005.09.018

American Heart Journal
Volume 151, Issue 4 , Pages 915.e1-915.e7 , April 2006

Article Tools

* Image Usage & Resolution